ArticleOncogene2021

Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance.

Sisi Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.